Berlin - Delayed Quote EUR

Lineage Cell Therapeutics Inc (BT3.BE)

Compare
0.5850
0.0000
(0.00%)
As of 8:08:25 AM GMT+1. Market Open.
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-22,765.0000
-28,566.0000
1,059.0000
-23,561.0000
-19,753.0000
Investing Cash Flow
4,799.0000
46,449.0000
-46,159.0000
9,745.0000
13,038.0000
Financing Cash Flow
14,110.0000
6,423.0000
1,632.0000
36,930.0000
29,865.0000
End Cash Position
28,144.0000
35,992.0000
11,936.0000
56,277.0000
33,183.0000
Interest Paid Supplemental Data
8.0000
10.0000
13.0000
13.0000
20.0000
Capital Expenditure
-291.0000
-674.0000
-413.0000
-340.0000
-64.0000
Issuance of Capital Stock
14,070.0000
6,625.0000
148.0000
30,865.0000
5,127.0000
Issuance of Debt
--
--
--
--
25,147.0000
Repayment of Debt
-53.0000
-54.0000
-32.0000
-20.0000
-26.0000
Repurchase of Capital Stock
-23.0000
-37.0000
-17.0000
-54.0000
-27.0000
Free Cash Flow
-23,056.0000
-29,240.0000
646.0000
-23,901.0000
-19,817.0000
12/31/2020 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers